Stock listing
Neurogene Inc.
Selected listing: A3EX79 · LS · EUR · DE
Neurogene Inc. (Lang & Schwarz: A3EX79), Health Technology. Latest release Oct 5, 2026: Neurogene Announces Inducement Grants Under Nasdaq Listing Rule…
- Ticker
- Lang & Schwarz: A3EX79
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Neurogene Inc.
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 5, 2026
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 4, 2026
Neurogene to Participate in H.C. Wainwright 28th Annual Global Investment Conference
September 8, 2026
Neurogene Reports Second Quarter 2026 Financial Results and Highlights Recent Updates
August 11, 2026
Neurogene Inc. Announces Pricing of $125 Million Public Offering
July 1, 2026
Events
Research Neurogene Inc.
Alternate listings
NGNE:NASDAQ
US · USD
Alternate listing for Neurogene Inc.; the primary context on this page is A3EX79:LS.
A3EX79:LSX
DE · EUR
Alternate listing for Neurogene Inc.; the primary context on this page is A3EX79:LS.
NGNE:BOATS
US · USD
Alternate listing for Neurogene Inc.; the primary context on this page is A3EX79:LS.
UU8:FWB
DE · EUR
Alternate listing for Neurogene Inc.; the primary context on this page is A3EX79:LS.
UU8:DUS
DE · EUR
Alternate listing for Neurogene Inc.; the primary context on this page is A3EX79:LS.
UU8:TRADEGATE
DE · EUR
Alternate listing for Neurogene Inc.; the primary context on this page is A3EX79:LS.
UU8:SWB
DE · EUR
Alternate listing for Neurogene Inc.; the primary context on this page is A3EX79:LS.